Tympanic Membrane Perforation
1
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Innovation PharmaceuticalsMA - Wakefield
1 program1
fiblast,gelatin sponge,fibrin gluePhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Innovation Pharmaceuticalsfiblast,gelatin sponge,fibrin glue
TympanogenPerf-Fix Otologic Gel Patch
Grace MedicalTympanoseal
Grace MedicalTympanoseal
Clinical Trials (4)
Total enrollment: 161 patients across 4 trials
A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18
Start: Mar 2015Est. completion: Jul 201620 patients
Phase 3Completed
Perf-Fix Study for Chronic Tympanic Membrane Repair
Start: Apr 2024Est. completion: Jan 202671 patients
N/ACompleted
Tympanoseal Clinical Study
Start: Jan 2024Est. completion: Apr 202645 patients
N/ARecruiting
Tympanoseal (Tympanic Membrane Device) Clinical Study
Start: Oct 2016Est. completion: Sep 202125 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 161 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.